Spetz-Hagberg A L, Larsson-Sciard E L
Unité de Biologie Moléculaire du Gène, U277 INSERM-UAC 115 CNRS, Institut Pasteur, Paris.
Res Immunol. 1989 Jun-Aug;140(5-6):517-25. doi: 10.1016/0923-2494(89)90117-x.
Treatment with a novel immunomodulator called linomide resulted in highly reduced levels of pathogenic anti-DNA antibodies in MRL-lpr/lpr mice compared to untreated mice. This reduction occurred without altering the total levels of serum immunoglobulins, implying that the compound does not have any direct B-cell suppressive effect. The possible role of T cells in regulating autoreactive B-cell clones is discussed.
与未治疗的小鼠相比,用一种名为里诺米德的新型免疫调节剂治疗的MRL-lpr/lpr小鼠体内致病性抗DNA抗体水平大幅降低。这种降低在不改变血清免疫球蛋白总水平的情况下发生,这意味着该化合物没有任何直接的B细胞抑制作用。文中讨论了T细胞在调节自身反应性B细胞克隆中的可能作用。